Since we all are like minded and fairly intelligent people for being long IBIO, I would like to hear from people what their fav small caps or pennies with a brief explanation why.
For me, EKNL, (although it has VAPOR volume lately) is a probable HUGE short squeeze that can happen, when their reverse merger with OEBIN and another. The Shorts have been caught naked 3million shares, and now there is a bit of litigation.
Another if UFFC, which is healthy fast food, that is getting contracts with the Us Military to open up several shops on bases. Once they get going, a good chance for going to all the bases.
I don't recommend buying EKNL as the litigation might go against eknl and they may have to reissue the shares. Then the shorts will be covered. A REAL GAMBLE.
Thanks for your insight, as I like to hear about interesting stocks.
NeuroMetrix Files 510(k) for SENSUS™ Pain Therapy Device
Press Release: NeuroMetrix, Inc. – 4 hours ago.. .
WALTHAM, Mass.--(BUSINESS WIRE)--
NeuroMetrix, Inc. (Nasdaq: NURO - News), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes reported today that it has filed a premarket notification, or 510(k), with the Food and Drug Administration (FDA) for its SENSUS Pain Therapy device. SENSUS is a non-invasive transcutaneous electrical nerve stimulator intended to be used in the symptomatic relief and management of chronic intractable pain, such as painful diabetic neuropathy. SENSUS employs the same sophisticated nerve stimulation technology as the Company’s NC-stat® DPNCheck™ device, and includes advanced features that the Company believes may address the technical and clinical limitations of existing nerve stimulators. The device also includes technology to maximize patient compliance, which is one of the fundamental challenges with pain therapy.
iBIO Number ONE
gypsy and others, sorry for misstake on one of my pick, the symbol is NVIV, it is called invivo therepudics, check it out, tell me what you think, it is in category with ibio, in that highly spec, but in cutting edge tech that could become a blockbuster.
IBIO first, Nuro for the potential, GNOM for the possibilites:
INVI, a real sleeper, their area is spinal cord damage, and attempting to prevent its extent, or hopefully to improve the already dis abled, a great stock to conduct dd on.AIS, Another choice, which is much more closer to being a "sure" thing, if there is ever a sure thing. Solid company, turned profitable last quarter, have partnerships in place with big pharma, are in drug delivery, rather than drug development, which therefore cuts out major biotech risks of failed clinical trials. I will throw out one more, psdv, a company that focuses on problens of the eye. Just recently won approval, along with their partner, alim, for a launch in latter half of this year in Europe, for a drug that is used to treat diabetes related eye disease. psdv has plenty of cash, they have revenue, and they have several new projects in the works. They have consistantly been in the $4 range, got beaten down a few months back to little over $1. Now over $2, and on the move in past week. took breather today. There is a good article in seeking alpha today about psdv. There you have it, one highly speculative, invo, which in lots of ways similar to ibio, and 2 other safer, but also with major potential, ais and psdv. I think some of you will find them worthwhile of your time glta
Do a little homework and you will see why 8)
For the record.I own IBIO as a pump trade ONLY. I do not see this stock as a lot of you do.I believe there will be a lot of feelings hurt and money lost within a few days of your big party day on May 1st.
Does anyone know when the AIS Financials are coming out? I read something that it may not be as good a people expect, so may be an opportunity to bottom fish? I do concede that I may miss a buyout. Thanks in advance!
Shadow, this stock would be much higher if the approval of PLX was in the bag. Even if May 1st is not what it's hoped to be then IBIO falls back to 1.25 - 1.30......! My point is: there is far more upside here than down. You're assuming the current PPS is factoring in an approval and it's not; quite the opposite. There's a lot of skepticism in the current PPS hence the light volume coupled with modest % PPS gains. We still have a lot of time between now and then but as of right now........the real gamble is being out of the stock!
IMO it's the perfect storm for a BIG gain........at least as of today's closing PPS. The trick here will be if the TA (street) guys jump on it before or after 5/1. It has to be popping up on TA screens especially after a third day closing PPS above its open on top of the 200 DMA......!
I have seen AIS, and I have read Scotts reasons why its going ot be bought out.
I really like that stock also, but the 3 dollar price tag is something I need to think about, and the fact it looks toppy. Why is that? What is holding that great stock back..